LIXT
Lixte Biotechnology Holdings Inc
NASDAQ: LIXT · HEALTHCARE · BIOTECHNOLOGY
$3.50
+0.00% today
Updated 2026-04-30
Market cap
$44.15M
P/E ratio
—
P/S ratio
20.35x
EPS (TTM)
$-1.26
Dividend yield
—
52W range
$1 – $6
Volume
0.0M
Lixte Biotechnology Holdings Inc (LIXT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0.00 | $200000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | -100.0% | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $462.00 | $592.00 | $615.00 | $128.00 | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | $0.00 | $200000.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — | — | 100.0% | — | — | — | — | — | — | — | — | — | — |
| R&D | $150100.00 | $423829.00 | $608733.00 | $496517.00 | $445542.00 | $1.33M | $1.01M | $879886.00 | $1.12M | $2.09M | $1.30M | $467258.00 | $40703.00 | $820906.00 | $1.22M | $1.74M | $1.35M | $898100.00 | $726232.00 | $254919.00 |
| SG&A | $299420.00 | $1.24M | $664202.00 | $1.05M | $436142.00 | $533449.00 | $1.09M | $494959.00 | $1.28M | $754440.00 | $833782.00 | $1.34M | $2.10M | $1.67M | $2.04M | $4.98M | $4.96M | $4.19M | $2.85M | $4.85M |
| Operating income | $-449982.00 | $-1.66M | $-1.27M | $-1.55M | $-881684.00 | $-1.87M | $-2.11M | $-1.38M | $-2.40M | $-2.65M | $-2.13M | $-1.81M | $-2.14M | $-2.49M | $-3.27M | $-6.72M | $-6.31M | $-5.09M | $-3.57M | $-5.11M |
| Operating margin | — | — | — | — | — | — | — | — | — | -1323.0% | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-561622.00 | $-1.65M | $-1.27M | $-1.55M | $-881684.00 | $-1.87M | $-3.58M | $-1.38M | $-2.40M | $-2.44M | $-2.13M | $-1.81M | $-2.13M | $-2.49M | $-3.26M | $-6.72M | $-6.30M | $-5.07M | $-3.57M | $-6.00M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | -1220.5% | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-562084.00 | $-1.65M | $-1.27M | $-1.55M | $-881684.00 | $-2.07M | $-3.58M | $-1.38M | $-2.77M | $-2.65M | $-2.13M | $-1.81M | $-2.14M | $-2.49M | $-3.26M | $-6.73M | $-6.31M | $-5.09M | $-3.60M | — |
| Interest expense | $0.00 | $0.00 | $1233.00 | $1232.00 | $1434.00 | $125.00 | $8.00 | $3.00 | $66.00 | $78.00 | $183.00 | $1375.00 | $4923.00 | $49723.00 | $3674.00 | $7414.00 | $8875.00 | $16233.00 | $16821.00 | $9158.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-488084.00 | $-1.65M | $-1.27M | $-1.55M | $-880250.00 | $-2.07M | $-3579.00 | $-1.38M | $-2.77M | $-2.85M | $-2.13M | $-1.81M | $-2.13M | $-2.39M | $-3.26M | $-6.73M | $-6.31M | $-5.09M | $-3.59M | $-6.01M |
| Net income growth (YoY) | — | -237.6% | +22.8% | -22.0% | +43.3% | -134.9% | +99.8% | -38318.6% | -101.2% | -3.1% | +25.1% | +15.3% | -18.0% | -12.1% | -36.6% | -106.1% | +6.2% | +19.4% | +29.5% | -67.6% |
| Profit margin | — | — | — | — | — | — | — | — | — | -1426.0% | — | — | — | — | — | — | — | — | — | — |